Growth Metrics

Marimed (MRMD) Change in Receivables (2016 - 2025)

Marimed has reported Change in Receivables over the past 12 years, most recently at $441000.0 for Q4 2025.

  • Quarterly Change in Receivables rose 2421.05% to $441000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $429000.0 through Dec 2025, up 679.73% year-over-year, with the annual reading at $429000.0 for FY2025, 679.73% up from the prior year.
  • Change in Receivables was $441000.0 for Q4 2025 at Marimed, down from $1.3 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $4.0 million in Q3 2021 and troughed at -$1.8 million in Q2 2021.
  • The 5-year median for Change in Receivables is -$15000.0 (2022), against an average of $242300.0.
  • Year-over-year, Change in Receivables crashed 16731.96% in 2021 and then surged 21057.14% in 2023.
  • A 5-year view of Change in Receivables shows it stood at $811000.0 in 2021, then plummeted by 102.59% to -$21000.0 in 2022, then increased by 9.52% to -$19000.0 in 2023, then changed by 0.0% to -$19000.0 in 2024, then soared by 2421.05% to $441000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Change in Receivables are $441000.0 (Q4 2025), $1.3 million (Q3 2025), and -$1.6 million (Q2 2025).